Company intelligence / Profile preview

Aventiv Research

Columbus, Ohio, United States

Ownership: Private
Employees: ~38
Development stage: Other

Overview

Aventiv Research is a clinical research organization (CRO) founded in 2007, specializing in Phase I-IV trials for pharmaceuticals, devices, and diagnostics across multiple therapeutic areas. It merged with Centricity Research in June 2022 and operates sites in Ohio and Arizona, employing approximately 38 people with $8.6M in revenue. It has contributed to 26 FDA-approved drugs through over 475 clinical trials for various sponsors.

Industry: Contract Research Organization

Partnerships

hyperCORE International

Beyond the preview

Go deeper on Aventiv Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aventiv Research.

Explore the full profile